Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00675363 · ClinicalTrials.gov registry record · NA

Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.

A NA study of Critical Illness, sponsored by Mount Sinai Hospital, Canada.

Completed
Registry status
NA
Development phase
410
Enrollment target
16
Study locations

NCT00675363 is a NA study of Critical Illness that has completed, run by Mount Sinai Hospital, Canada. The registered enrollment target is 410 participants, below the 3,134-participant average among 91 other Critical Illness trials with a reported enrollment target (87% lower). The trial reports 16 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00675363, a NA study of Critical Illness, has completed, sponsored by Mount Sinai Hospital, Canada.

COMPLETED
Registry status
NA
Development phase
410 participants
Enrollment target
16
Study locations

Study Summary

The purpose of this study is to determine whether the use of both a nurse-driven sedation protocol and daily sedative interruption, compared with a sedation protocol alone, result in better outcomes for mechanically ventilated adults.

Conditions Studied

Critical Illness

Interventions

  • PROCEDURE Protocolized Sedation
  • PROCEDURE Protocolized sedation, with daily interruption

Study Locations (16)

Ontario

  • Hamilton Health Sciences - Hamilton
  • St. Joesph's Healthcare - Hamilton
  • Sunnybrook HSC - Toronto
  • St. Michael's Hospital - Toronto
  • Mount Sinai Hospital - Toronto
  • Toronto General Hospital - Toronto
  • Toronto Western Hospital - Toronto

British Columbia

  • Royal Columbian Hospital - New Westminster
  • Surrey Memorial Hospital - Vancouver
  • Providence Health Care-St. Paul's Hospital - Vancouver

Alberta

  • Royal Alexandra Hospital - Edmonton
  • Walter C. Mackenzie Health Sciences Centre - Edmonton

California

  • Long Beach Memorial Medical Center - Long Beach

Massachusetts

  • Tuft's Medical Centre - Boston

Manitoba

  • Winnipeg Health Sciences Centre - Winnipeg

Quebec

  • Maisonneuve Rosemount - Montreal

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2008-01
Est. Completion 2012-10-17
Phase NA

Sponsor

Mount Sinai Hospital, Canada

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00675363

The ClinicalTrials.gov registry entry for NCT00675363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,134-participant average among 91 other Critical Illness trials with a reported enrollment target (87% lower). The listed sponsor is Mount Sinai Hospital, Canada, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Protocolized Sedation is the first listed.

NCT00675363 reports 16 study locations spanning 7 distinct geographic areas - top geographies include Ontario, British Columbia, Alberta.

Frequently Asked Questions

What is clinical trial NCT00675363 about?

NCT00675363 is a clinical study titled "Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.". The purpose of this study is to determine whether the use of both a nurse-driven sedation protocol and daily sedative interruption, compared with a sedation protocol alone, result in better outcomes for mechanically ventilated adults.

What is the current status of trial NCT00675363?

This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2008-01. Estimated completion is 2012-10-17.

What conditions does trial NCT00675363 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT00675363?

The interventions under investigation include: Protocolized Sedation (PROCEDURE), Protocolized sedation, with daily interruption (PROCEDURE).

Who is sponsoring clinical trial NCT00675363?

This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00675363 being conducted?

This trial has 16 study locations across California, Massachusetts, Alberta, British Columbia, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Critical Illness

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.